FLEX LTD.

FLEX

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Eventide Asset Management

AI Signal

# Signal Note: Eventide Initiates FLEX Position **Context:** Flex Ltd.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Eventide Asset ManagementNEWFeb 13, 2026

Shares: 220,510Value: $13.4M

# Signal Note: Eventide Initiates FLEX Position **Context:** Flex Ltd. is a contract manufacturer (CDMO) with significant exposure to biotech/pharma production, not a drug developer. Eventide's $13.4M entry suggests conviction in outsourced manufacturing tailwinds, likely driven by continued biotech funding cycles and capacity constraints in GLP-1 production or other high-demand therapeutics. **Catalyst timing:** No imminent binary events; this is a thematic play on sustained biotech spending and manufacturing demand through 2024-2025.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

CPRT1 fund DECK1 fund LITE1 fund NTAP1 fund GPI1 fund IMMX1 fund PI1 fund UNP1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: